Analysts debate Senate drug pricing bill’s likelihood of making an impact

The Prescription Drug Pricing Reduction Act, introduced last month by Senate Finance Committee Chairman Chuck Grassley, R-Iowa, and Ranking Member Ron Wyden, D-Ore., has passed a Senate committee and now awaits further action.
As the bill stands right now, it would significantly change Medicare Parts D and B, reduce out-of-pocket costs for Americans, save Medicare about $85 billion during the next decade and, in the short term, save Medicaid about $15 billion, according to a press release issued by Grassley.
Experts consulted for this story on the bill’s viability and (Read more...)

Full Story →